Written by Hannah Nichols
Published: Friday 7 October 2016 at www.medicalnewstoday.com
Different triggers spark stroke, injuries, and neurodegenerative diseases, but the molecular chain of events responsible for brain cell death in these conditions are the same. Johns Hopkins researchers have isolated the single protein at the end of the chain that delivers the fatal blow and hacks up a cell’s DNA.
The findings – published in the journal Science – could pave the way for new therapies to stop the process in its tracks and potentially prevent brain cell death. (more…)
Post-Stroke Depression Eight Times Higher than Average, Danish Study Finds
The incidence of depression in the early months after a first stroke was eight times higher than average, according to a population-based study in Denmark, and patients with a history of prior depression or more severe stroke were especially vulnerable.After three months the rate fell significantly, yet it was still two times higher at two years, according to the study published online September 7 in JAMA Psychiatry. (more…)
For decades, warfarin was the only oral blood thinner available to reduce the risk of stroke for patients with atrial fibrillation. Warfarin use is cumbersome, because it requires ongoing blood test to monitor the effect and has numerous drug and food interaction. Now a number of non-vitamin K antagonist oral anticoagulant (NOAC) drugs are available for patients with atrial fibrillation and claim to revolutionize the care for patients with atrial fibrillation. (more…)
UCLA-led study shows that stent retrievers can provide benefits more than seven hours after onset
Article by: Enrique Rivero | September 27, 2016
Time is of the essence when getting people stricken with acute ischemic strokes to treatment. And the use of stent retrievers — devices that remove the blood clot like pulling a cork out of a wine bottle — has proven to be a breakthrough for removing the life-threatening blockage of blood flow to the brain. (more…)
The formation of SAFE in 2004 was the first step in a journey of consolidation, expansion and a quest for sustainability, all of which are necessary requirements to enable influencing and campaigning over the sustained periods of time needed to effect real improvement and change.
This is a constant struggle, some SSO’s have ceased to exist, but overall there are now more than 30 SSO’s in Europe, and over a dozen now employ paid staff, supported by volunteers, many of whom are stroke survivors or family members. One of the youngest SSOs in SAFE, yet very active and enthusiastic about the cause is the SSO from Former Yugoslav Republic of Macedonia. We spoke with Maja Bozinovska, neurologist and the President of the “Здружение за борба против мозочен удар” about their SSO’s membership at SAFE, what does it mean for their organisation, but also what is the work they do and challenges they meet every day. (more…)
As more people survive stroke, the burden of care and support is great and increasing. However, the implementation of guidelines, interventions and organized stroke care varies across Europe, contributing to variations of outcomes for stroke survivors.
The challenges are to go back to designing more effective ways of preventing stroke, said Prof. Charles Wolfe from King’s College London, the lead researcher of the Burden of Stroke Report.
King’s College London has been commissioned by the Stroke Association in the UK, on behalf of the Stroke Alliance for Europe, SAFE, to undertake a project on the burden of stroke and how patients’ needs are met by health care provision in Europe. (more…)